Loading data
HCWBNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 43.39 k USD | 1.61 m USD | 2.28 m USD | 4.14 m USD | 0 USD |
| Gross profit | 10.85 k USD | 959.4 k USD | 560.36 k USD | 2.59 m USD | 0 USD |
| Research and development expense | 5.44 m USD | 6.39 m USD | 7.68 m USD | 9.34 m USD | 8.17 m USD |
| Operating profit | -13.16 m USD | -29.46 m USD | -25.72 m USD | -15.08 m USD | -13.37 m USD |
| Interest expense | 845.05 k USD | 654.28 k USD | 283.04 k USD | 126.66 k USD | 0 USD |
| Profit before tax | -7.96 m USD | -30.02 m USD | -24.99 m USD | -14.9 m USD | -12.86 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -7.96 m USD | -30.02 m USD | -24.99 m USD | -14.9 m USD | -12.86 m USD |
| Net income attributable to common shareholders | -22.3 m USD | -30.02 m USD | — | — | — |
| Basic earnings per share | -10.63 USD/share | -30.96 USD/share | -0.7 USD/share | -0.42 USD/share | -0.69 USD/share |
| Diluted earnings per share | -10.63 USD/share | -30.96 USD/share | -0.7 USD/share | -0.42 USD/share | -0.69 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.